Terfenadine

This classification denotes a histamine-1 receptor antagonist with the molecular formula C32H41NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7BA5G9Y06Q, chemically known as 1-piperidinebutanol, alpha-(4-(1,1-dimethylethyl)phenyl)-4-(hydroxydiphenylmethyl)- but generally known as terfenadine, which bears US NIH Compound Identifier 5405. European Medicines Agency schedules Terfenadine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10920MIG. The term TERFENADINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 29, No. 10 1975, List 15). World Health Organization schedules terfenadine in its Anatomical Therapeutic Chemical (ATC) Classification. TERFENADINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule terfenadine under HS 29333999 and SITC 51574. As of Q4 2014, TERFENADINE remains the US FDA Preferred Term for this commodity. Terfenadine bears US NLM identifiers UMLS ID C0085173 and NCI Concept Code C29494. SMILES: OC(C1CCN(CC1)CCCC(O)C1CCC(C(C)(C)C)CC1)(C1CCCCC1)C1CCCCC1.